ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Galera Therapeutics Inc

Galera Therapeutics Inc (GRTX)

0.14
-0.0135
(-8.79%)
Closed March 29 04:00PM
0.185
0.045
(32.14%)
After Hours: 07:59PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.185
Bid
0.1739
Ask
0.185
Volume
4,313,835
0.1314 Day's Range 0.185
0.0853 52 Week Range 3.59
Market Cap
Previous Close
0.1535
Open
0.1576
Last Trade Time
Financial Volume
$ 696,452
VWAP
0.161446
Average Volume (3m)
2,095,459
Shares Outstanding
54,392,170
Dividend Yield
-
PE Ratio
-0.12
Earnings Per Share (EPS)
-1.14
Revenue
-
Net Profit
-62.22M

About Galera Therapeutics Inc

Galera Therapeutics Inc is a biopharmaceutical company focused on developing therapeutics that have the potential to transform radiotherapy in cancer. Galera Therapeutics Inc is a biopharmaceutical company focused on developing therapeutics that have the potential to transform radiotherapy in cancer.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Galera Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GRTX. The last closing price for Galera Therapeutics was $0.15. Over the last year, Galera Therapeutics shares have traded in a share price range of $ 0.0853 to $ 3.59.

Galera Therapeutics currently has 54,392,170 shares outstanding. The market capitalization of Galera Therapeutics is $7.61 million. Galera Therapeutics has a price to earnings ratio (PE ratio) of -0.12.

GRTX Latest News

Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates

MALVERN, Pa., March 28, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a biopharmaceutical company focused on developing a pipeline of novel, proprietary therapeutics that...

Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]

      SECURITIES AND EXCHANGE COMMISSION   WASHINGTON, D.C. 20549   SCHEDULE 13D (RULE 13d-101)   INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO...

Galera Reports Third Quarter 2023 Financial Results and Recent Corporate Updates

FDA confirms need for new trial for avasopasem; GRECO trials with rucosopasem to be discontinued Company evaluating potential strategic options to optimize shareholder value MALVERN, Pa., Nov...

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13G   Under the Securities Exchange Act of 1934 (Amendment No.__...

Galera Shares Halted After FDA Says Avasopasem Needs Additional Phase 3 Trial

Adriano Marchese Shares in Galera Therapeutics were halted from premarket trading on Tuesday after the Food and Drug Administration said the company needs an additional Phase 3 trial for its...

Form 8-K - Current report

false 0001563577 0001563577 2023-10-31 2023-10-31     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT...

Galera Announces Receipt of Type A Meeting Minutes and Strategic Update

FDA confirms need for new trial for avasopasem for severe oral mucositis (SOM) GRECO-2 trial did not pass futility analysis; Company will discontinue both GRECO trials Company reviewing...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.067-26.58730158730.2520.2520.131415734600.18527461CS
4-0.0646-25.88141025640.24960.260.13148735300.21188671CS
120.035223.49799732980.14980.290.131420954590.21418446CS
260.00462.549889135250.18040.290.085329048040.18757663CS
52-2.305-92.57028112452.493.590.085324642500.55026676CS
156-8.835-97.94900221739.0210.790.085320353892.11110242CS
260-12.315-98.5212.519.50.085314028402.24072972CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AVTXAvalo Therapeutics Inc
$ 22.08
(364.84%)
31.9M
NXLNexalin Technologies Inc
$ 1.50
(92.31%)
11.67M
CEROCERo Therapeutics Holdings Inc
$ 3.112
(90.92%)
24.08M
BDRXBiodexa Pharmaceuticals PLC
$ 1.6201
(88.60%)
88.37M
KYCHKeyarch Acquisition Corporation
$ 12.30
(75.58%)
196.62k
BOLDBoundless Bio Inc
 14.25
(-76.24%)
767.63k
PMECPrimech Holdings Ltd
$ 1.2999
(-66.50%)
8.28M
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.1816
(-44.45%)
21.92M
GMDAGamida Cell Ltd
$ 0.036
(-39.19%)
89.18M
NBSTWNewbury Street Acquisition Corporation
$ 0.042279
(-38.28%)
1.75k
NKLANikola Corporation
$ 1.035
(13.85%)
163.84M
GMDAGamida Cell Ltd
$ 0.036
(-39.19%)
89.18M
BDRXBiodexa Pharmaceuticals PLC
$ 1.6201
(88.60%)
88.37M
MARAMarathon Digital Holdings Inc
$ 22.56
(2.22%)
86.14M
AKANAkanda Corporation
$ 0.1166
(-29.29%)
80.34M

GRTX Discussion

View Posts
FROZENFLAME FROZENFLAME 1 week ago
And some news will be great !
👍️0
FROZENFLAME FROZENFLAME 1 week ago
Need some volume !
👍️0
FROZENFLAME FROZENFLAME 1 week ago
Nice size bid !
👍️0
FROZENFLAME FROZENFLAME 1 week ago
Interesting price, I’m in
$GTRX
👍️0
Nealio Nealio 2 months ago
$GRTX - wants to move even higher...funds buying in? Anyone monitoring that? I need to find those links for Institutional reporting
👍️0
glenn1919 glenn1919 2 months ago
GRTX............................https://stockcharts.com/h-sc/ui?s=GRTX&p=W&b=5&g=0&id=p86431144783
👍️0
crowin crowin 3 months ago
weeeee
👍️0
Nealio Nealio 3 months ago
Looks like a lot of people gave up and sold too low...it may punch UP further tomorrow...certainly held gains ah's. News pending?
👍️0
urge2surge urge2surge 4 months ago
13G 12% stake. Looks ready. Mc only 7 mill, cash and tangibles 28 mill. No cash needed until 2025. Buyout candidate IMO.
👍️0
0210 0210 4 months ago
Close Watch: GRTX 8 x 34 + other daily technicals curling up. Now @0.14 - 0.15 > 0.1610 - 0.171(Parabolic SAR) >> 0.32, and then up to 0.50, +233% short-term target price.
👍️0
0210 0210 4 months ago
GRTX @0.14 - 0.15 fwiw. "...risk/reward is still favorable. 28 mil cash on hand, and laying off over 70% of the workforce and stopping the 2 trials, should be ample enough money to carry them through all of 2024. Already have made it clear that they don't want to go through another trial for Avasopasem, as it is costly and time consuming, so if you are buying or going long here, you are simply playing[translation: ACCUMULATING, lol ] for one of the possible strategic maneuvers..."
Source: Click here.
👍️0
0210 0210 4 months ago
TP: 0.25 min 0.50 max and/or 0.42 ave.(short-term TP = 3x or +200% from 0.14-.0.15 current pps) .

Source: 3 stock analysts. Click here.
👍️0
glenn1919 glenn1919 5 months ago
GRTX...................https://stockcharts.com/h-sc/ui?s=GRTX&p=W&b=5&g=0&id=p86431144783
👍️0
knrorrel knrorrel 5 months ago
Why ? do you think it will go higher soon ?


👍️0
Triple nickle Triple nickle 5 months ago
Never see these prices again
👍️0
koolmc koolmc 5 months ago
lol you were telling peeps to dump few days ago
👍️0
Tom turtles Tom turtles 5 months ago
Dumped at .145..TY stock God's...In .0919
👍️0
chumfm chumfm 5 months ago
Seen this many times.This goose is cooked.Expect chapter 11 in the near future.Good luck and good trading.
👍️0
Tom turtles Tom turtles 5 months ago
You may as well unload now...geez.. what a fiasco
👍️0
Here Today Here Today 5 months ago
And in the case of IPIX like it is here with Galera, the FDA constantly wants more testing and more testing. But yet for an experimental MRNA shot which scientists and the medical community will not truly know the effects for another 5 years on one’s health, they green light. In my opinion, it’s all about who greases whose palms!!!
👍️0
Here Today Here Today 5 months ago
Overreaction??? This looks to be going down the route of IPIX. Both of these companies Galera and Innovation Pharma had a product for OM and both of them have been rejected by the FDA. It’s amazing to me the stupidity of how it goes especially since they have nothing that really works right now and patients that develop OM usually have to stop cancer treatments and then decide whether or not to continue once the symptoms subside and heal. And the cost for a severe OM patient to be treated is very, very expensive.
👍️0
wickerman wickerman 5 months ago
$GRTX where's the guy who was pumping this trash all over iHub?
Next stop is BK and delisting.
👍️0
ATM123 ATM123 5 months ago
Do the company has any IP property for buyout/merger with all the trails cancellations...
👍️0
hondaboost hondaboost 5 months ago
Over reaction: GRTX, cash: $28.4 M. "Galera estimates that its balance of cash, cash equivalents and short-term investments as of September 30, 2023 was $28.4 million. or $0.7/share . "
👍️0
Here Today Here Today 5 months ago
Not bad??? Check out market reaction. Down 50% pre market.
👍️0
sc00pnDump sc00pnDump 5 months ago
News out, need to do another phase 3 tests and submit holding back other drug to save money… not bad
👍️0
mistercellphoneman mistercellphoneman 5 months ago
website is back up
👍️0
OmegaMoney29 OmegaMoney29 5 months ago
Wow
👍️0
ATM123 ATM123 5 months ago
Website is down...Whats going on
👍️0
Golden Cross Golden Cross 5 months ago
Should be hearing something this week
👍️0
OmegaMoney29 OmegaMoney29 5 months ago
I bet so
👍️0
Golden Cross Golden Cross 5 months ago
It is possible to fill that $2 gap Omega... Depends on how good the news is...
👍️0
work-n-hard work-n-hard 5 months ago
...with Good Weather. lol
👍️0
powerbattles powerbattles 5 months ago
Fully loaded at an average.185
👍️0
OmegaMoney29 OmegaMoney29 5 months ago
Early Christmas 🎄
👍️0
work-n-hard work-n-hard 5 months ago
Gap fill would be excellent.
👍️0
OmegaMoney29 OmegaMoney29 5 months ago
fda news run to $2 tomorrow??
👍️0
work-n-hard work-n-hard 5 months ago
Yep, I think that it's leaking out that news is coming. Maybe this afternoon or tomorrow???
👍️0
Golden Cross Golden Cross 5 months ago
Think we have seen the bottom...Looking better here
👍️0
work-n-hard work-n-hard 5 months ago
https://www.nasdaq.com/press-release/galera-schedules-type-a-meeting-with-fda-to-discuss-next-steps-for-avasopasem-2023-09
👍️0
bluebird50 bluebird50 5 months ago
What’s the intended date?
👍️0
powerbattles powerbattles 5 months ago
$GRTX According to the FDA guidance document titled “Formal Meetings Between the FDA and Sponsors or Applicants of PDUFA Products Guidance for Industry”, after a Type A meeting, the FDA will provide written feedback to the sponsor or applicant within 14 calendar days of the meeting. This feedback will include a summary of the meeting, any agreements reached during the meeting, and any action items that need to be addressed by either party.

Agreements that could be reached during a Type A meeting include:

Agreement on clinical trial design: The FDA may agree to a sponsor’s or applicant’s proposed clinical trial design.

Agreement on endpoints: The FDA may agree to a sponsor’s or applicant’s proposed endpoints for a clinical trial.

Agreement on statistical analysis: The FDA may agree to a sponsor’s or applicant’s proposed statistical analysis plan for a clinical trial.

Agreement on labeling: The FDA may agree to a sponsor’s or applicant’s proposed labeling for a drug product.
👍️0
work-n-hard work-n-hard 5 months ago
? I sent it the day before.
👍️0
Triple nickle Triple nickle 5 months ago
Give it 10 minutes
👍️0
work-n-hard work-n-hard 5 months ago
Sent an email to co., but no reply yet.
👍️0
sc00pnDump sc00pnDump 5 months ago
It’s not over…;)
👍️0
Golden Cross Golden Cross 5 months ago
Should have known when the posting stopped by a few people that they sold and it was over
👍️0
Golden Cross Golden Cross 5 months ago
Yep between the company selling shares and shorts u can't win with BIO's... just be ready to sell the spikes and i fucked up yesterday early... about all gone now...
👍️0
work-n-hard work-n-hard 5 months ago
...or the result of complete silence.
👍️0
frans frans 5 months ago
we see an sell off here ??????time will tell
👍️0

Your Recent History

Delayed Upgrade Clock